Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Abeona Therapeutics (ABEO) recorded Liabilities and Shareholders Equity of $171.92 million in Q3 2026, down 25.6% from $231.1 million a year earlier and down 4.2% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Abeona Therapeutics reported Liabilities and Shareholders Equity of $219.57 million, up 101.6% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $108.93 million in FY2024 (+70.2%), $64 million in FY2023 (-0.3%), $64.21 million in FY2022 (-19.3%) and $79.59 million in FY2021 (-47.4%).
  • The Q3 2026 figure is the lowest quarterly Liabilities and Shareholders Equity since Q1 2025.
  • On a year-over-year basis, Liabilities and Shareholders Equity rose in six of the last eight quarters, with growth averaging 53.4%.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 150.2% in Q2 2024, against a decline of 67.4% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $179.51 million (Q2 2026), $198.49 million (Q1 2026) and $219.57 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 197.43 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 147.68 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 119.92 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 205.00 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn 171.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 171.92 Mn
Jun 30, 2026 179.51 Mn
Mar 31, 2026 198.49 Mn
Dec 31, 2025 219.57 Mn
Sep 30, 2025 231.10 Mn
Jun 30, 2025 246.23 Mn
Mar 31, 2025 99.36 Mn
Dec 31, 2024 108.93 Mn
Sep 30, 2024 120.59 Mn
Jun 30, 2024 134.00 Mn
Mar 31, 2024 74.83 Mn
Dec 31, 2023 64.00 Mn
Sep 30, 2023 66.09 Mn
Jun 30, 2023 53.55 Mn
Mar 31, 2023 53.35 Mn
Dec 31, 2022 64.21 Mn
Sep 30, 2022 38.76 Mn
Jun 30, 2022 44.72 Mn
Mar 31, 2022 55.17 Mn
Dec 31, 2021 79.59 Mn
API Access

Abeona Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ABEO&period=max&api_key=YOUR_API_KEY